Monthly Archives: September 2019

A Director at Ulta Beauty Inc (NASDAQ: ULTA) is Buying Shares

Yesterday, a Director at Ulta Beauty Inc (ULTA – Research Report), Charles Heilbronn, bought shares of ULTA for $58.89M. Following this transaction Charles Heilbronn’s holding in the company was increased by 15% to a total of $523 million. This is

AnaptysBio Inc (ANAB) Gets a Hold Rating from Stifel Nicolaus

Stifel Nicolaus analyst Derek Archila reiterated a Hold rating on AnaptysBio Inc (ANAB – Research Report) today. The company’s shares closed last Monday at $34.99, close to its 52-week low of $34.51. According to TipRanks.com, Archila has 0 stars on

The President and CMO of Burlington Stores is Exercising Options

Today it was reported that the President and CMO of Burlington Stores (BURL – Research Report), Jennifer Vecchio, exercised options to sell 15,000 BURL shares at $54.58 a share, for a total transaction value of $2.98M. In addition to Jennifer

Merrill Lynch Keeps a Buy Rating on Starbucks Corp (SBUX)

In a report issued on September 27, Gregory Francfort from Merrill Lynch reiterated a Buy rating on Starbucks Corp (SBUX – Research Report), with a price target of $100.00. The company’s shares closed last Monday at $88.42. According to TipRanks.com,

Merrill Lynch Keeps Their Buy Rating on Ametek Inc (AME)

Merrill Lynch analyst Andrew Obin reiterated a Buy rating on Ametek Inc (AME – Research Report) on September 27 and set a price target of $105.00. The company’s shares closed last Monday at $91.82, close to its 52-week high of

Analysts Are Bullish on These Healthcare Stocks: Aquestive Therapeutics Inc (AQST), Adaptimmune Therapeutics (ADAP)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aquestive Therapeutics Inc (AQST – Research Report) and Adaptimmune Therapeutics (ADAP – Research Report) with bullish sentiments. Aquestive Therapeutics Inc (AQST) In